PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL

Clinical trial NCT07380984 · RECRUITING

Trial details

NCT number: NCT07380984
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Natural Killer/T-cell Lymphoma

Start date: 2026-03-01
Primary completion: 2029-02-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.